2 unchanged sentences
Exhibit Description
+Added: Share Purchase Agreement, by and between Rhythm Pharmaceuticals Netherlands B.V.
+Added: and Xinvento B.V., dated February 27, 2023.
Amended and Restated Certificate of Incorporation.
Amended and Restated Bylaws.
+Added: Summary of Non-Employee Director Compensation Policy.
Certification of the Principal Executive Officer, as required by Section 302 of the Sarbanes-Oxley Act of 2002 (18 U.S.C.
13 unchanged sentences
RHYTHM PHARMACEUTICALS, INC.
−Removed: November 8, 2022
President and Chief Executive Officer
(Principal Executive Officer)
−Removed: November 8, 2022
/s/ Hunter C.
2 unchanged sentences
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.